Key result
Combining medicamentous and non-medicamentous therapy significantly lowered cardiovascular risk factors compared to medicamentous therapy alone (P<0.001).
Why the study?
Does combined medicamentous and non-medicamentous therapy improve cardiovascular risk factors in patients with coronary or cerebrovascular disease?
Does combined medicamentous and non-medicamentous therapy improve cardiovascular risk factors in patients with coronary or cerebrovascular disease?
Combining pharmacological treatments with lifestyle modifications significantly improves cardiovascular risk factor profiles in patients with established cardiovascular or cerebrovascular disease.
Answers are grounded in this paper and cite their sources.
Supports combined therapy for risk factor control in secondary prevention; leaves open effects on clinical events.
INTRODUCTION: In a chain of cardiovascular episodes, risk factors (RF) and bad habits represent the first link. OBJECTIVE: The purpose of the study was to determine, during six months, on four examinations (the first, and three follow-ups after the second, fourth and sixth month), the following: physical activity (PA) alteration and the number of cigarettes smoked; the effect of antihypertensive beta-blockers and ACE inhibitors on systolic and diastolic arterial tension; the effect of metmorfin therapy on BMI, glycaemia, total cholesterol level (TCL) and triglycerides in diabetics compared to healthy individuals; the effect of hypolipidaemics on blood TCL and triglycerides in patients with angina pectoris (AP); the effect of betablocker therapy on TCL. METHOD: This was a multicentric interventional study. Secondary prevention of coronary disease and cerebrovascular conditions was applied in the first half of 2005. There were 185 general practitioners from 38 health centres in Serbia, and patients of both sexes were included with the verified diagnosis of coronary disease and/or cerebrovascular condition. They had demographic data verified as well as data of being genetically (non)predisposed for AP, hypertension, myocardial infarction, stroke and diabetes mellitus. Descriptive and differential statistical methods were used for study result analysis. RESULTS: Out of 1189 patients, there were 51.4% of women and 48.6% of men. The average age was 59.45 +/- 9.77 years. The population was homogeneous by sex and the factor of being genetically (non)predisposed for AP. There was a significant difference in examinations in four contacts in PA and cigarette smoking (p < 0.0001). Systolic and diastolic pressure, TCL and triglycerides were significantly decreased by medicaments (p < 0.05) and more significantly so associated with nonmedicamentous measures (p < 0.001). Metmorfin significantly decreased the glycaemic level (p < 0.001) both in diabetics and patients with a reduced tolerance level to glucose. In patients who took betablockers, there was lowering of TCL. CONCLUSION: Taking medicaments significantly lowers RF, and more significantly so when associated with a non-medicamentous therapy.
No takes yet. Share an insight, caveat, or question.
Lapčević et al. (2007) studied Coronary disease and/or cerebrovascular condition (n=1,189). Medicamentous and non-medicamentous therapy vs. Medicamentous therapy alone was evaluated on Systolic and diastolic pressure, total cholesterol level, and triglycerides (p=<0.001). Combining medicamentous and non-medicamentous therapy significantly lowered cardiovascular risk factors compared to medicamentous therapy alone (P<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: